Article Information
- Received April 13, 2012
- Revision received February 6, 2013
- Accepted February 13, 2013
- First published March 27, 2013.
- Version of record published March 27, 2013.
Author Information
Author contributions
Author contributions: E.S.S., J.-H.L., and G.F.G. designed research; E.S.S., J.-H.L., and N.N.S. performed research; E.S.S. and G.F.G. contributed unpublished reagents/analytic tools; E.S.S., J.-H.L., B.M.D., and K.M.A. analyzed data; E.S.S., J.-H.L., B.M.D., K.M.A., and G.F.G. wrote the paper.
Disclosures
- Received April 13, 2012.
- Revision received February 6, 2013.
- Accepted February 13, 2013.
This work was supported by the National Institutes of Health (NIH; Grants T32 DK063922 to E.S.S., UL1 RR024153 to E.S.S. and G.F.G., R01 NS33730 to K.M.A., and R01 DK093525 and NS035790 to G.F.G.) and the National Center for Research Resources, a component of the NIH and the NIH Roadmap for Medical Research (Grants R01 NS035790, R01 DK093525, and R01 NS033730, T32 DK063922, and UL1 RR024153). We thank Michael Burcham for preparation of figures, Pam Cornuet and Timothy McMurray for technical assistance, Michael S. Gold for use of his calcium imaging equipment, and Abbott Laboratories for their generous gift of the TRP antagonists A-967079 and A-889425.
The authors declare no competing financial interests.
- Correspondence should be addressed to E.S. Schwartz, Ph.D., Center for Pain Research, University of Pittsburgh, W1402 BST, 200 Lothrop St., Pittsburgh, PA 15213. schwartzee{at}upmc.edu
Online Impact